BiotechTube
Evolution Research Group

Evolution Research Group

Little Falls, United States· Est.
ergclinical.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $25M

Overview

Evolution Research Group (ERG) is a private, revenue-generating clinical research organization (CRO) and site network focused on complex and early-phase trials. The company differentiates itself through a large, specialized patient database, centralized operations, and therapeutic expertise in Central Nervous System (CNS) and metabolic disorders. Recent strategic moves, including acquisitions and the launch of a full-service CRO division, position ERG for growth by offering sponsors an integrated solution from site-level execution to broader trial management services.

PsychiatryNeurologyPainAddictionSleep DisordersNASHDiabetesTobacco

Technology Platform

Centralized clinical trial operations platform integrating a proprietary site network, patient database (>215,000), specialized recruitment, full-service CRO capabilities (via Lotus), and rater training (CNS Ratings).

Funding History

1
Total raised:$25M
Series A$25M

Opportunities

The growing complexity of clinical trials in CNS and metabolic diseases favors specialized operators like ERG.
Expansion into full-service CRO capabilities allows it to capture more value per sponsor relationship and offer integrated solutions.
Increased focus on trial diversity aligns with its community outreach model.

Risk Factors

Revenue is exposed to sponsor R&D cycles in its core therapeutic areas.
Integrating acquisitions and new CRO services poses operational execution risk.
The market is highly competitive with large global CROs and other niche providers, creating pricing pressure.

Competitive Landscape

ERG competes with large global CROs (IQVIA, ICON, PPD), other specialized site networks and site management organizations (SMOs), and a growing array of decentralized trial technology providers. Its differentiation lies in its owned site infrastructure, deep therapeutic expertise, and hybrid site/CRO model.

More companies in Digital Health & Biotech SaaS →More companies in United States →